You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API fosaprepitant


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing fosaprepitant

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Actavis Pharma Inc FOSAPREPITANT fosaprepitant 0591-4385 EDETATE DISODIUM
Actavis Pharma Inc FOSAPREPITANT fosaprepitant 0591-4385 HYDROCHLORIC ACID
Actavis Pharma Inc FOSAPREPITANT fosaprepitant 0591-4385 MEGLUMINE
Actavis Pharma Inc FOSAPREPITANT fosaprepitant 0591-4385 POVIDONE K12
Actavis Pharma Inc FOSAPREPITANT fosaprepitant 0591-4385 WATER
Spes Pharmaceuticals Inc FOCINVEZ fosaprepitant 82243-1001 BETADEX SULFOBUTYL ETHER SODIUM
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing fosaprepitant

Company Ingredient NDC Excipient
Sandoz Inc fosaprepitant 0781-3497 ANHYDROUS LACTOSE
Sandoz Inc fosaprepitant 0781-3497 EDETATE DISODIUM
Sandoz Inc fosaprepitant 0781-3497 HYDROCHLORIC ACID
Sandoz Inc fosaprepitant 0781-3497 POLYSORBATE 80
Sandoz Inc fosaprepitant 0781-3497 SODIUM HYDROXIDE
NorthStar RxLLC fosaprepitant 16714-120 ANHYDROUS LACTOSE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for fosaprepitant

Excipient focus: ANHYDROUS LACTOSE

fosaprepitant drug variants not containing ANHYDROUS LACTOSE

Company Ingredient NDC
Actavis Pharma Inc fosaprepitant 0591-4385
Hepalink USA Inc fosaprepitant 81952-911
Spes Pharmaceuticals Inc fosaprepitant 82243-1001
Amneal Pharmaceuticals LLC fosaprepitant dimeglumine 70121-2631
Athenex Pharmaceutical Division LLC fosaprepitant dimeglumine 70860-783
Chia Tai Tianqing Pharmaceutical Group Co Ltd fosaprepitant dimeglumine 71731-5111
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM

Excipient focus: EDETATE DISODIUM

Excipient focus: EDETATE SODIUM

Excipient focus: HYDROCHLORIC ACID

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MEGLUMINE

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE K12

Excipient focus: SODIUM HYDROXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group